Evidence map›Paper›PMID 42082500›Full record

ArticleNature communications2026

Self-assembling scaffolds epigenetically reactivate and electroactively guide neuronal regeneration to restore central neural circuits.

Shiqiang Tong, Shuai Ye, Fenfen Ma, Xiaoying Xie, Yinzhe Sun, Chuchu Ma, Tiantian Shi, Zheng Cheng, Chang Li, Weili Han and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Shiqiang Tong *Shanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Shuai Ye *Department of Rehabilitation Medicine, Huashan Hospital, Center for Clinical Neuro-AI, Institute for Translational Brain Research, State Key Laboratory of Brain Function and Disorders and Ministry of Education Frontiers Center for Brain Science, Fudan University, Shanghai, China.ORCID http://orcid.org/0009-0003-2475-3779
Fenfen MaShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Xiaoying XieShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Yinzhe SunShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Chuchu MaShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Tiantian ShiDepartment of Rehabilitation Medicine, Huashan Hospital, Center for Clinical Neuro-AI, Institute for Translational Brain Research, State Key Laboratory of Brain Function and Disorders and Ministry of Education Frontiers Center for Brain Science, Fudan University, Shanghai, China.
Zheng ChengShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Chang LiShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Weili HanSchool of Medicine, Shanghai University, Shanghai, China.
Laozhi XieShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Songlei ZhouShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
Jianing GongShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-7317-8238
Chen HuangBasic Medicine Experimental Teaching Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yukun HuangDepartment of Pharmacology and Chemical Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0002-3711-367X
Gan JiangDepartment of Pharmacology and Chemical Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0003-2011-741X
Xiaolin LiuDepartment of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Bing LiResearch Center for Clinical Medicine, Jinshan Hospital Affiliated to Fudan University, Shanghai, China.
Feng ZengDepartment of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Jingru GongDepartment of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Zhihua WangDepartment of Emergency, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China. wzhys@163.com.
Xiaoling GaoDepartment of Pharmacology and Chemical Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shellygao1@sjtu.edu.cn.ORCID http://orcid.org/0000-0001-6789-3059
Qiyong MeiDepartment of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China. meiqiyong@smmu.edu.cn.
Wei-Guang LiDepartment of Rehabilitation Medicine, Huashan Hospital, Center for Clinical Neuro-AI, Institute for Translational Brain Research, State Key Laboratory of Brain Function and Disorders and Ministry of Education Frontiers Center for Brain Science, Fudan University, Shanghai, China. liwg@fudan.edu.cn.ORCID http://orcid.org/0000-0002-3442-7518
Jun ChenShanghai Pudong Hospital & Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China. chenjun@fudan.edu.cn.ORCID http://orcid.org/0000-0003-1330-9616

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32201170National Natural Science Foundation of China (National Science Foundation of China) 82373814National Natural Science Foundation of China (National Science Foundation of China) 82471324National Natural Science Foundation of China (National Science Foundation of China) 82473850Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund) 23S41900100
6 · The paper itself

Abstract

Central nervous system (CNS) injury is a leading cause of death and long-term disability worldwide. Neurological deficits reflect disruption of central neural circuits. A major barrier to circuit repair is the intrinsically low regenerative potential of adult CNS neurons-linked in part to failure of injury-induced nuclear export of class IIa histone deacetylases (notably HDAC5)-together with a hostile post-injury microenvironment. Here we present a multifunctional nanosystem, encapsulating the class IIa HDAC4/5-selective inhibitor LMK-235 and featuring an electroactive polyaniline coating with asymmetrically distributed 5-hydroxytryptamine moieties. Upon reaching the lesion, our nanosystem assembles into large-pore scaffolds that (i) inhibit the activity of nuclear-retained class IIa HDACs in neurons and thereby reactivate intrinsic regenerative programs, (ii) regulate microglial activation to mitigate neuroinflammation, and (iii) provide an electroactive interface promoting activity-dependent synaptic reconnection. This multi-pronged approach illustrates an integrated platform with translational potential for CNS disorders in which circuit disconnection constrains recovery.

Indexed as

Epigenesis, GeneticNerve RegenerationNeuronsTissue ScaffoldsAnimalsHistone Deacetylase InhibitorsHistone DeacetylasesMiceMicrogliaHistone Deacetylase InhibitorsHistone Deacetylases

Identifiers

PMID42082500
PMCPMC13347008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.